Citizens Business Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,500
| Closed | -$510K | – | 123 |
|
|
2022
Q2 | $510K | Hold |
3,500
| – | – | 0.07% | 191 |
|
|
2022
Q1 | $572K | Hold |
3,500
| – | – | 0.07% | 190 |
|
|
2021
Q4 | $594K | Hold |
3,500
| – | – | 0.07% | 195 |
|
|
2021
Q3 | $661K | Hold |
3,500
| – | – | 0.09% | 183 |
|
|
2021
Q2 | $593K | Hold |
3,500
| – | – | 0.08% | 193 |
|
|
2021
Q1 | $494K | Hold |
3,500
| – | – | 0.07% | 191 |
|
|
2020
Q4 | $455K | Hold |
3,500
| – | – | 0.07% | 195 |
|
|
2020
Q3 | $510K | Hold |
3,500
| – | – | 0.09% | 172 |
|
|
2020
Q2 | $518K | Hold |
3,500
| – | – | 0.09% | 176 |
|
|
2020
Q1 | $381K | Hold |
3,500
| – | – | 0.08% | 187 |
|
|
2019
Q4 | $403K | Hold |
3,500
| – | – | 0.07% | 200 |
|
|
2019
Q3 | $281K | Hold |
3,500
| – | – | 0.05% | 222 |
|
|
2019
Q2 | $254K | Hold |
3,500
| – | – | 0.04% | 231 |
|
|
2019
Q1 | $327K | Hold |
3,500
| – | – | 0.06% | 219 |
|
|
2018
Q4 | $255K | Hold |
3,500
| – | – | 0.05% | 239 |
|
|
2018
Q3 | $306K | Hold |
3,500
| – | – | 0.05% | 241 |
|
|
2018
Q2 | $345K | Hold |
3,500
| – | – | 0.06% | 230 |
|
|
2018
Q1 | $417K | Hold |
3,500
| – | – | 0.07% | 217 |
|
|
2017
Q4 | $445K | Hold |
3,500
| – | – | 0.07% | 222 |
|
|
2017
Q3 | $411K | Hold |
3,500
| – | – | 0.07% | 224 |
|
|
2017
Q2 | $279K | Buy |
+3,500
| New | +$279K | 0.05% | 250 |
|